Katerina Akassoglou/Gladstone Institutes
Oct 21, 2025, 06:18
Katerina Akassoglou Receives Zenith Fellows Award to Advance Alzheimer’s Research
Gladstone Institutes shared on LinkedIn:
”Katerina Akassoglou has opened doors to understanding how the blood protein fibrin is involved in Alzheimer’s and other neurodegenerative diseases.”
Katerina Akassoglou, PhD, of the Gladstone Institutes, has led groundbreaking research into the interplay between the brain, blood vessels, and immune system, revealing how these connections contribute to Alzheimer’s and other neurological disorders.
In recognition of her work, she has been named a 2025 recipient of the Alzheimer’s Association’s Zenith Fellows Award.
Read the full article here.
More winner stories featured in Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy